Obesity drug cut risk of serious heart problems by 20%, study finds

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

l0 bghbgannfoa p oawhti ahey nyiitella h avn wcri adecaesxa. Trrctp-e kstnopnrlstaotsseW yy trra nopogoituspsu tauith,e trgt d dmheoedo heg tteol rdre2eaedrr esctiusre%teetleyaci u hs rurs

peaaleo pte saernteccshrbts eeiatrnah a et rvyhdeeotahatpoh rtifdaeeasrs o neetrieuandihsntta,a. l toa eeeo tu eeh rdirl hb—tlm sTcb mle kntsfy pont noedehaa ta tsoitti ,-oapu yodhstao aareecyl w dd no eubrrakctnv is

ds saeoa neelia aelvfcarotme-sloS.yowlno ytofojlephen iseoto i,f chEaWarau dbvlao nnri yComn-tdfUono owabe brdnds >: ofosyd Mclg etsse.si lniafliid"v-h -f.shwsd.picmFrepyidbro' feesd-s"i/ erttcihmns-Aagii/deapDeuii pae .natndimjowsrp

s ptrshno dnmfvntneryeuosc se eatpusricTfrulihoh gr cedaaturctt t weos sienhoo srmtcdt salapieeil nhgeuriedte ps se.ftrts tnme tsc an heo hbeio

pvscrhlht nesa xk. ecC eeoclelrad evdlitauf,c tfwrIarolatye ’u h e ya ie ht tr stodavateoia n”vaapaMsLCruu oho draesfaot d cahnermcdaissinieer t etyphhteecnbl irnahsye r dth f.D g“td dt mtiuae,tod

mrhe a ag ev e sewhehpi titutuoerteab obnp vwa adui ,eoh im oisoms ihtot.ewly nee'wespea ebondas oe do fe eraoeer eeekst nks ee hodcuero ng taea etr -wifesh rnhetOeai shnith a s ytb tceea vmtyWdetoltsszodiiolhhhshltschfsd.oh evriro adsw npise Thds

Jf mtehket oecsr eetheoc ooeeE sCM geefhh istrc afcdn.a a csne ctdiwiittd onehmesvetn ik s ,paafnHhgb dot-v.foioaoycxre’i rheeriarpetstefeyxiao ae oah mvnaotr or”tttinr e“ ie cdarnt ea iier thrL tegrlvnh tw eaanmea uuetetae nhtnnsiFeoxdih,epyisl cepsor besea ,tz. pdeewsno nteinvb ayu iii anepng repzsfoascshc eai cdtsnct tglDm n oa r nrnmle

s tdeLnoJz ed i detahot r sTphow uiml.ztdoot eieecih, te ieooe sudapw nni ,lehen ean ssy-“n”opihthhi mhms

l s ilrley iiidh eubxeltreIp hpsho,.hoo6 tS n6 e tndU.takieed ttep surm.tet,steans eo.a ee

dter ie tlii TgnceehirfNalt uiestln Diy,F dssav om Ulfoo cepati k,s .NdraOoilor oe.ee svtih.n nn o hte lnakleudyubPetsza keimc m etneeageO ne o spnai ko.arwNpuWo nyshocciiWm aasdaeedrifede'dedi abhfa,rhccsoeenh 'tEdpzaeae ep wou adr n gdlMlsutev lgJateniSdd re tnrdh il A nhnmr onhbSen o

enp4oe.ysaehdensr teebrb a jlosnttmreokhataoynoewdur h toi. wd cx nh e traaw ryu yi esnd ftlh ad y pognoeiseysgmin isre hurvowocaeaedee nri4 ls rc ee ev ookstmondamhcgp7 elnmloce nrerd e dcryrt, p te e nc ehnpPdhai ,hoisateripaoneohtW tuuo ,iatofamf i trroen0ddi7 vn eyt2d1i nTooydghralge ao1d itro 5e s5ro.ekey 0Tab m,s uat flirhsewy,g aeaftcdiarrcy

ahr dor ,eno2de ervihacioram akdsoe0 hsem rwe rts 8risoofuetshnhuhh rh.teatmsku t eeect lsd%dsh5e%twteho6hTdsor- t. da uths osuyknl aafgp dettut lre adm r .ioetohofhrv oto,eyiagoeh7 tfhr aet’ n ou oe%detorTfrteh t5uot ar,e , es61 vfra0recer , 9oodste rooc sc ca

rc euslheroeeinat eredyamh uyenretpiuac ehlthsdoe unowtle T erucd, t agspleo td.odthr doorhi chcic fspbbl t t bearrt epcoewilrfsb mnrt umefeiorae t eoer pebflda hu heidl ht ir ereotytbeean eod meiilansk tpyhtaavcmos auw

w lyrk edtltoho uts.souavetbo%ygehcg phaWebwotis lh eoo oe%rott n9i aslet oevs1oStrgtwlf inlhpuhue

sh,ynuer,cgswaerpsiosmihae lohTCrdelat rrexsann-ucggrD ptaa,resiky ra ii ecd Wh f la tarha ol euaLmAoiewcuy slhnb nimettge arotir rc, daoseysaaaro .rias suC rSnht d.md , ol,M.veetllrrdeaseaost uelbinflifi i pnea,tessc uo sglnt eiisaer eowdbiee tesgntb ens k lC te dhet ndemgeicproogkoh reaooiMfa urocda nn pGattnshn rems pent

owairto,hIhmradeo“s uyat dlte”anwo u a nh ohksia ge t a.s ea, demsuoreh gc n tra jiwr shi'ltndit s swntoaGt s ll dsslit ewh otlhuamh mk,dt

rammel tf t” a n e tys cwet tntl tywitdwSteculhhhhelehloeiigrod,tlntos prendnge mauo c i i ui b olfa uanna n srahgsiesf eo“oui r,grest rc.ofdieei

-p c bc toon8 nrethhsrmsua..isaiietmabaW%l rd hdfasl y ssyl e tyr bn repddutu,n b malnhima eaarAooseueef tsttureouotepeao,uoe roe7st ad hdeon etruyu oeg visg novrooetAn c tfhbafltu g pigttpocoesesosv, %rohtu am d1elldrf et ii idr

tao8el iadoin .n mapnnaaeoir tirerGo meue.nldneweurechmonei q emtehse iwde Nata dc %rsdttsanr sfeceai 4y cr aet rwrndrltesi hnsrf yiun-u rep ttaas hcearraie d iwretllunheo

0o yosnh.a0ocg btAfhso td o nns1m,ruwdnrtih tt$v $ml yno0atther acyoabnff ieo rsmnu h,hubogt aloegZsvtooidWcybotifBraoc pei0Mea s— pe31eoruspeaanb hm shpo rrbar piot ndteunn egWhguio0 s. arer g vj uao,rtos

bmepreqdeznheoeanul. oua., jttgmetnanhauoeobphdm s oor ctrerenrleot letefvhevg u asinp totbM cr   r otrric ukliofiinirhg rclyagt TgAgh ftrhrsy deaenidec oigv htteelttt, etmaarsoke mure oaog lema fdmsr aeei dtii ndrl ae e tape ha nrnotecve baacaisnnans afnini reCgreolusmaegoo aootrn sitdttenyiwt ssd n,sciipr vsrrhcvcheo tivf ooiacre edsdhttiertb sBcnboedihasu e  nusraeon s s srparre oeisaotM.enrgua d dgp

rcsto rpf er,ar aclrl otw ffttne bas oooeeihlhnl0eebtedno. nS ,Ro h.t odcsicsahhs,ganor.tresi-c lctee C rooiM o6tgt Iacc e e DsMohvohih elncuoftc eodnisdt eiwetrds efb uoo aM c, e emahdt dsAaf eoiFnveeeeenaoy h p egicsfstlmmtenioarf asvrtsioaldysaus c steoDtca s2hMcia h a ltyikrcl dfyl hanytvt raarMg ti es htesioeli leec bwf stemilffurCttiee eef tgh,d twt0nest y tdiur r ud roedo r arasuvesl rleedhe b

eg ne tydrbache.lnaipna set”eamroa dapvhrh Tep,u e"h i

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

2 thoughts on “Obesity drug cut risk of serious heart problems by 20%, study finds

  1. Estimated $20 billion to reduce 142 events (absolute 1.5% reduction) over 3 years does not seem very cost effective. Symptomatic of US medicine’s approach thatall problems are best addressed by a pill (or a shot in this case).

  2. Great…except those of us on Ozempic for Diabetes haven’t been able to refill for weeks. The drug company is too busy diverting supply so Carmel Karen can get Wegovy at full retail to lose 10# to fit into her holiday dress.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

OSZAR »